Drug Chatter -- Tracking biopharma stock chatter

💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…

Profile for GTx, Inc. (GTXI)

« Back to company index

GTXI Chatter Timeline

Stock Ticker for GTXI

Most Active Tweeters for GTXI

No tweets found

Recent Tweets for GTXI

EdgarInsider @EdgarInsider
New Form 8-K [Press/News Current Report] entry filed by $ONCT $GTXI #OncternalTherapeutics, Inc https://t.co/jjK2k4A7xn
June 21st 2021, 1:06pm
Allstocknews @Allstocknews
$GTXI Oncternal Therapeutics Reports Granting of Inducement Award Under Nasdaq Listing Rule 5635(c)(4) From our Stock News Alerts App
June 1st 2021, 8:06pm
Allstocknews @Allstocknews
$GTXI New Form 424B5 for Oncternal Therapeutics, Inc. From our Stock News Alerts App
May 28th 2021, 11:05pm
EdgarInsider @EdgarInsider
New Form 8-K [Press/News Current Report] entry filed by $ONCT $GTXI #OncternalTherapeutics, Inc https://t.co/oyygqJVOYT
May 28th 2021, 9:05pm
Allstocknews @Allstocknews
$GTXI New Form 3 for Oncternal Therapeutics, Inc. From our Stock News Alerts App
May 27th 2021, 10:05pm
FlashAlert_me @FlashAlert_me
$GTXI [15s. delayed] filed SEC form 4: Director Wills Robert James: Transacted Derivative Securities on 2021-05-25… https://t.co/5zhkTfV4od
May 27th 2021, 10:05pm
Allstocknews @Allstocknews
$GTXI New Form 4 for Oncternal Therapeutics, Inc. From our Stock News Alerts App
May 27th 2021, 10:05pm
FlashAlert_me @FlashAlert_me
$GTXI [15s. delayed] filed SEC form 4: Director KISNER DANIEL L: Transacted Derivative Securities on 2021-05-25. https://t.co/htScbc4Xv2
May 27th 2021, 10:05pm
FlashAlert_me @FlashAlert_me
$GTXI [15s. delayed] filed SEC form 3: General Counsel/Secretary Leavitt Chase C.: https://t.co/gcHYlZCHo9
May 27th 2021, 10:05pm
FlashAlert_me @FlashAlert_me
$GTXI [15s. delayed] filed SEC form 4: Director THEUER CHARLES: Transacted Derivative Securities on 2021-05-25. https://t.co/A6peeEDAAm
May 27th 2021, 10:05pm
FlashAlert_me @FlashAlert_me
$GTXI [15s. delayed] filed SEC form 4: Director CARTER MICHAEL G: Transacted Derivative Securities on 2021-05-25. https://t.co/RmYfi4VFXP
May 27th 2021, 10:05pm
FlashAlert_me @FlashAlert_me
$GTXI [15s. delayed] filed SEC form 3: Chief Technology Officer Krishnan Rajesh: https://t.co/6Ciw2R39EG
May 27th 2021, 10:05pm
FlashAlert_me @FlashAlert_me
$GTXI [15s. delayed] filed SEC form 4: Director Nakanishi Xin: Transacted Derivative Securities on 2021-05-25. https://t.co/1PXKAfK5pe
May 27th 2021, 10:05pm
FlashAlert_me @FlashAlert_me
$GTXI [15s. delayed] filed SEC form 4: Director LARUE WILLIAM R: Transacted Derivative Securities on 2021-05-25. https://t.co/WQoo8cHwfk
May 27th 2021, 10:05pm
FlashAlert_me @FlashAlert_me
$GTXI [15s. delayed] filed SEC form 4: Director HALE DAVID F: Transacted Derivative Securities on 2021-05-25. https://t.co/UBCJEgazEX
May 27th 2021, 10:05pm
FlashAlert_me @FlashAlert_me
$GTXI [15s. delayed] filed SEC form 4: Director MAZANET ROSEMARY: Transacted Derivative Securities on 2021-05-25. https://t.co/xNxrAPt0dt
May 27th 2021, 10:05pm
Allstocknews @Allstocknews
$GTXI Oncternal Therapeutics to Participate in Jefferies Virtual Healthcare Conference From our Stock News Alerts App
May 26th 2021, 12:05pm
Allstocknews @Allstocknews
$GTXI New Form 8-K for Oncternal Therapeutics, Inc. From our Stock News Alerts App
May 20th 2021, 10:05am
EdgarInsider @EdgarInsider
Alert [Press/News Current Report] / Form 8-K filed with the SEC $ONCT $GTXI #OncternalTherapeutics, Inc https://t.co/BjjaMwAaMV
May 20th 2021, 10:05am
FlashAlert_me @FlashAlert_me
$GTXI [15s. delayed] filed form 8-K on May 20, 06:02:39 https://t.co/DtUud4lKpG
May 20th 2021, 10:05am
Allstocknews @Allstocknews
$GTXI Oncternal Therapeutics Presents Updated Interim Data for TK216 in Patients with Relapsed or Refractory From our Stock News Alerts App
May 19th 2021, 9:05pm
Allstocknews @Allstocknews
$GTXI Oncternal Therapeutics Presents Updated Interim Data for Cirmtuzumab in Combination with Ibrutinib at A From our Stock News Alerts App
May 19th 2021, 9:05pm
Allstocknews @Allstocknews
$GTXI Oncternal Therapeutics Announces Appointment of Salim Yazji as Chief Medical Officer From our Stock News Alerts App
May 17th 2021, 8:05pm
StkOptionCoach_ @StkOptionCoach_
RT @StockTradersHQ: HQ Alert: Sold $GTXI at $2.16 to lock in the 27% profit on this trade.
May 8th 2021, 5:05am
StkOptionCoach_ @StkOptionCoach_
RT @StockTradersHQ: We are now up 26% on our $GTXI position.
May 8th 2021, 5:05am
EdgarInsider @EdgarInsider
A Form 10-Q [Quarterly Report] filing has been made with the SEC: $ONCT $GTXI #OncternalTherapeutics, Inc.… https://t.co/zljtN015b9
May 6th 2021, 11:05pm
Allstocknews @Allstocknews
$GTXI New Form 10-Q for Oncternal Therapeutics, Inc. From our Stock News Alerts App
May 6th 2021, 9:05pm
EdgarInsider @EdgarInsider
SEC Form 8-K [Press/News Current Report] filed by $ONCT $GTXI #OncternalTherapeutics, Inc https://t.co/5L2FcIjif8
May 6th 2021, 8:05pm
Allstocknews @Allstocknews
$GTXI Oncternal Provides Business Update and Announces First Quarter 2021 Financial Results From our Stock News Alerts App
May 6th 2021, 8:05pm
Allstocknews @Allstocknews
$GTXI Oncternal Therapeutics Reports Granting of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) From our Stock News Alerts App
May 3rd 2021, 8:05pm

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2021. All rights reserved.